PHK
ALT icon

Point72 Hong Kong’s Altimmune ALT Stock Holding History

Point72 Hong Kong’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-4,218
Closed -$26K – 1878
2022
Q1 		$26K Sell
4,218
-1,178
-22% -$8.68K ﹤0.01% 1482
2021
Q4 		$49K Buy
+5,396
New +$57.3K ﹤0.01% 1344

Other funds holding ALT

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Point72 Hong Kong's ALT Position: Q2 2022 in Review

Point72 Hong Kong sold out of Altimmune (ALT) in Q2 2022, closing a stake of 4,218 shares — an estimated $26K sold.

Point72 Hong Kong first reported a position in ALT in Q4 2021 and held it in 2 quarters. The position peaked at $49K in Q4 2021. 110 funds tracked by Wall St. Rank hold ALT as of Q2 2022.

  • Point72 Hong Kong reported no remaining Altimmune position as of Q2 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 4,218 Altimmune shares in Q2 2022, an estimated $26K.
  • Point72 Hong Kong first reported a position in Altimmune in Q4 2021 and held it in 2 quarters.
  • Point72 Hong Kong's Altimmune position peaked at $49K in Q4 2021.
  • 110 funds tracked by Wall St. Rank held Altimmune as of Q2 2022.

Based on Point72 Hong Kong's 13F filing for Q2 2022, filed 15 Aug 2022.